Michael B Hoffman bought $160k of ANVS
director at Annovis Bio, Inc.. 39,200 shares at an average of $4.08, traded Nov 24, 2025, filed Nov 25, 2025.
Score components
- +15RoleDirector
- +11Trade size$160k at market
- 0Relative to holdingsHoldings up 1.6%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying4 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -24.1%, 3m -44.4%, 6m -57.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-116084, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | POpen-market purchase Common Stock | +1,489 | $4.13 | $6,150 | 2,492,028 | Nov 25, 2025 |
| Nov 24, 2025 | POpen-market purchase Common Stock | +9,200 | $3.85 | $35k | 2,501,228 | Nov 25, 2025 |
| Nov 24, 2025 | POpen-market purchase Common Stock | +415 | $4.14 | $1,718 | 2,501,643 | Nov 25, 2025 |
| Nov 24, 2025 | POpen-market purchase Common Stock | +28,096 | $4.15 | $117k | 2,529,739 | Nov 25, 2025 |
Related signals
Other insiders at Annovis Bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $143k 76,344 shares | +2% | |
| 54Moderate | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $1.5M 713,800 shares | +28% | |
| 32Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $194k 45,000 shares | +2% | |
| 31Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $160k 39,200 shares | +2% | |
| 23Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $70k 20,000 shares | +1% | |
| 20Weak | ANVSbuy Annovis Bio, Inc. | Michael B Hoffman director | $32k 15,000 shares | +1% | |
| 58Moderate | Annovis Bio, Inc. | Michael B Hoffman director | $2.0M 975,610 shares | +66% | |
| 48Moderate | Annovis Bio, Inc. | Maria-Luisa Maccecchini President & CEO | $200k 97,561 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.